agilon health (NYSE:AGL) Price Target Lowered to $7.00 at Stifel Nicolaus

agilon health (NYSE:AGL) had its price objective lowered by Stifel Nicolaus from $8.00 to $7.00 in a research note published on Wednesday morning, Benzinga reports. Stifel Nicolaus currently has a hold rating on the stock.

AGL has been the subject of several other reports. JPMorgan Chase & Co. cut shares of agilon health from an overweight rating to a neutral rating and decreased their price objective for the stock from $17.00 to $9.00 in a research report on Friday, January 5th. Evercore ISI dropped their price objective on agilon health from $7.00 to $6.00 and set an in-line rating on the stock in a report on Wednesday, February 28th. Benchmark cut their target price on agilon health from $13.00 to $9.00 and set a buy rating on the stock in a research report on Thursday, February 29th. Royal Bank of Canada lowered their price target on agilon health from $11.00 to $8.00 and set an outperform rating for the company in a report on Wednesday, February 28th. Finally, Citigroup started coverage on shares of agilon health in a research report on Monday, April 22nd. They set a neutral rating and a $6.00 price objective for the company. One research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of Hold and an average target price of $9.32.

agilon health Price Performance

AGL stock opened at $4.83 on Wednesday. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.51 and a quick ratio of 1.51. The firm has a market capitalization of $1.99 billion, a P/E ratio of -7.45 and a beta of 0.52. The business’s 50-day moving average is $5.43 and its two-hundred day moving average is $9.14. agilon health has a 1 year low of $4.41 and a 1 year high of $26.75.

agilon health (NYSE:AGL) last issued its earnings results on Tuesday, February 27th. The company reported ($0.41) earnings per share for the quarter, missing the consensus estimate of ($0.28) by ($0.13). agilon health had a negative net margin of 5.76% and a negative return on equity of 21.74%. The firm had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same period last year, the business earned ($0.14) EPS. The firm’s revenue was up 71.8% compared to the same quarter last year. Analysts anticipate that agilon health will post -0.35 earnings per share for the current fiscal year.

Institutional Investors Weigh In On agilon health

Several hedge funds have recently made changes to their positions in AGL. CWM LLC raised its stake in agilon health by 83.7% during the 3rd quarter. CWM LLC now owns 1,585 shares of the company’s stock valued at $28,000 after acquiring an additional 722 shares during the last quarter. Signaturefd LLC raised its stake in shares of agilon health by 73.7% during the third quarter. Signaturefd LLC now owns 1,673 shares of the company’s stock worth $30,000 after purchasing an additional 710 shares during the last quarter. Quest Partners LLC purchased a new stake in shares of agilon health during the fourth quarter worth approximately $45,000. Neo Ivy Capital Management acquired a new stake in shares of agilon health during the fourth quarter worth $47,000. Finally, Simplicity Wealth LLC purchased a new position in agilon health in the 1st quarter valued at $65,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.